SEARCH

SEARCH BY CITATION

References

  • 1
    Instituto Nacional de Estadistica. Spain census data, up-dated in January 2009. http://www.ine.es
  • 2
    Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT: Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341:12371239
  • 3
    Young C, Losikoff P, Chawla A, Glasser L, Forman E: Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007; 47:540544
  • 4
    Flores-Chávez M, Fernández B, Puente S, Torres P, Rodríguez M, Monedero C, Cruz I, Gárate T, Cañavate C: Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clin Infec Dis 2008; 46:e44e47
  • 5
    Forés R, Sanjuán I, Portero F, Ruiz E, Regidor C, López-Vélez R, Linares M, Gil S, Ojeda E, Krsnik I, Bautista G, Vallejo C, García-Marco J, Fernández MN, Cabrera JR: Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant 2007; 39:127128
  • 6
    Abalo M, Adelantado M, Areal C, Castrillo A, Castro A, Cid J, Eiiras A, Flores J, Cabrera J: Tracing of one year of Chagas screening at the Centro de Transfusión de Galicia (C.T.G) concerning a positive blood donor. Abstract XVIIth Regional Congress of the ISBT, Europe, Madrid, Spain, 2007
  • 7
    Pérez de Pedro I, Martín Rico P, Santamaría S, Faez Y, Blanc P, Pascual MªJ, Cuesta MªA, Villalta MªC, Muñoz Pérez MI, Vidales I, Heiniger AI: Caso clínico de Chagas transfusional. Enf Emerg 2008; 1:1415
  • 8
    Piron M, Vergés M, Muñoz J, Casamitjana N, Sanz S, Maymó RM, Hernández JM, Puig L, Portús M, Gascón J, Sauleda S: Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2008; 48:18621868
  • 9
    Schmunis GA, Cruz JR: Safety of Blood Supply in Latin America. Clin Microb Reviews 2005; 18:1229
  • 10
    Spanish Hemovigilance Network Report. Informe hemovigilancia año, Ministerio de Sanidad y Consumo, 2007, p. 24
  • 11
  • 12
    Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components
  • 13
    Leiby DA, Nguyen ML, Notari EP: Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008; 48:22222228
  • 14
    Garraud O, Assal A, Pelletier B, Danic B, Kerleguer A, David B, Joussemet M, De Micco P: Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95:226231
  • 15
    Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland Ø, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S: The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010, 98: 468478, Published Online: Jan 28 2010
  • 16
    Spencer B, Steele W, Custer B, Kleinman S, Cable R, Wilkinson S, Wright D, for the Retrovirus Epidemiology Donor Study (REDS) II group: Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion 2009; 49:23352345